We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.

Amplification of the Neu (ErbB-2 or HER-2) receptor tyrosine kinase occurs in 20 to 30% of human mammary carcinomas, correlating with a poor clinical prognosis. We have previously demonstrated that four (Y1144 Y1201, Y1227 and Y1253) of the five known Neu autophosphorylation sites can independently mediate transforming signals. The transforming potential of two of these mutants correlates with their capacity to recruit Grb2 directly to Y1144 (YB) or indirectly through Shc to Y1227 (YD). Here, we demonstrate that these transformation-competent neu mutants activate extracellular signal-regulated kinases and stimulate Ets-2-dependent transcription. Although the transforming potential of three of these mutants (YB, YD, and YE) was susceptible to inhibition by Rap1A, a genetic antagonist of Ras, the transforming potential of YC was resistant to inhibition by Rap1A. To further address the significance of these ErbB-2-coupled signaling molecules in induction of mammary cancers, transgenic mice expressing mutant Neu receptors lacking the known autophosphorylation sites (NYPD) or those coupled directly to either Grb2 (YB) or Shc (YD) adapter molecules were derived. In contrast to the NYPD strains, which developed focal mammary tumors after a long latency period with low penetrance, all female mice derived from YB and YD strains rapidly developed mammary tumors. Although female mice from several independent YB or YD lines developed mammary tumors, the YB strains developed lung metastases at substantially higher rates than the YD strains. These observations argue that Grb2 and Shc play important and distinct roles in ErbB-2/Neu-induced mammary tumorigenesis and metastasis.

Pubmed ID: 11238891 RIS Download

Mesh terms: Adaptor Proteins, Signal Transducing | Adaptor Proteins, Vesicular Transport | Alleles | Animals | Binding Sites | Breast Neoplasms | Cell Line | Chromatography, Affinity | DNA-Binding Proteins | Female | GRB2 Adaptor Protein | Glutathione Transferase | Humans | Immunoblotting | Kinetics | Mammary Neoplasms, Animal | Mice | Mice, Transgenic | Mitogen-Activated Protein Kinases | Neoplasm Metastasis | Phosphorylation | Precipitin Tests | Protein Structure, Tertiary | Proteins | Proto-Oncogene Protein c-ets-2 | Proto-Oncogene Proteins | Rats | Receptor, ErbB-2 | Recombinant Fusion Proteins | Repressor Proteins | Shc Signaling Adaptor Proteins | Signal Transduction | Src Homology 2 Domain-Containing, Transforming Protein 1 | Terminal Repeat Sequences | Time Factors | Trans-Activators | Transcription Factors | Transcription, Genetic | Transcriptional Activation | Transfection | rap1 GTP-Binding Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: P30 CA030199
  • Agency: NCI NIH HHS, Id: CA74507
  • Agency: NCI NIH HHS, Id: P30 CA30199

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.